Trip Sitters & Psychedelic Guides in Alabama
We Provide Trip Sitting & Guiding Services in Every Major City
This list is not meant to be exhaustive. We provide our trip sitting and guiding services in all major cities in Alabama, including those which are not listed above. If we can physically get ourselves to you, we will sit for you. If you are curious whether we are able to service your area specifically, please contact us.
Substances We Sit With
The one caveat to us being able to provide trip sitting and guiding services is that we cannot provide your substance of choice for personal consumption—we are unable to help with sourcing. Please understand that psychedelics are still federally controlled substances and you assume all the risk associated with possessing and consuming these medicines.
We are here to facilitate intentional psychedelic experiences where you feel supported along the entire journey—from preparation to sacred ceremonial experience to integration. We facilitate your inner healing by holding a safe, comfortable, non-judgmental space.
**Psychedelic Passage does not provide psychoactive or controlled substances nor are we licensed therapists, counselors, or medical professionals. We are a harm reduction company offering trip sitting & integration coaching services.**
Psychedelic Reform in Alabama
The psychedelic renaissance is evolving rapidly and the legal status of psychedelic substances is seeing widespread reconsideration. Although there aren’t any updates on psychedelic reform in Alabama, The University of Alabama at Birmingham began studying the benefits of psychedelics for substance abuse, depression, anxiety, PTSD, and pain, in 2021. Current research is being led by UAB’s Dr. Peter Hendricks, who aims to understand the efficacy of psilocybin in treating cocaine addiction. Dr. Hendricks and colleagues from Johns Hopkins University also recieved a $4 million federal grant to conduct three-year studies on the efficacy of psilocybin for sustainable smoking cessation. This federal grant was the first in 50 years for research on psychedelic drugs.